Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Purtilo

Showing results (81-90 of 214) with videos related to

Pageof 22
Sort By:
The Nebraska Medical Journal|October 1, 1984
Cancer cytogeneticsW G Sanger, J O Armitage, D T Purtilo
Microbiology and Immunology|January 1, 1986
Serological differences between human T-lymphotropic virus type-I (HTLV-I) and HTLV-III/LAVS Harada, D T Purtilo, Y Koyanagi, et al.
Annals of the New York Academy of Sciences|January 1, 1984
A multifactorial model for the development of AIDS in homosexual menJ A Sonnabend, S S Witkin, D T Purtilo
Archives of Pathology & Laboratory Medicine|December 1, 1987
Ontogeny and regulation of the immune systemJ G Sharp, D A Crouse, D T Purtilo
Clinics in Laboratory Medicine|March 1, 1988
Epstein-Barr virus--associated lymphoproliferative lesionsD S Harrington, D D Weisenburger, D T Purtilo
AIDS Research|February 1, 1986
Decision analysis of the HTLV-III screening test for blood donorsL B Ellwein, D T Purtilo, R B Purtilo
International Journal of Cancer|August 15, 1985
Host cell range of adult T-cell leukemia virus. I. Viral infectivity and binding to various cells as detected by flow cytometryF Sinangil, S Harada, D T Purtilo, et al.
International Journal of Cancer|December 15, 1982
Cell-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK)-cell activity in the X-linked lymphoproliferative syndromeS Harada, T Bechtold, J K Seeley, et al.
The American Journal of Medicine|October 1, 1989
Detection of X-linked lymphoproliferative disease using molecular and immunovirologic markersD T Purtilo, H L Grierson, H Ochs, et al.
Cancer Genetics and Cytogenetics|February 1, 1984
Inherited partial trisomy #15 complicated by neuroblastomaW G Sanger, J Howe, R Fordyce, et al.
Pageof 22

Showing results (81-90 of 214) with videos related to

Sort By:
Pageof 22
The Nebraska Medical Journal|October 1, 1984
Cancer cytogeneticsW G Sanger, J O Armitage, D T Purtilo
Microbiology and Immunology|January 1, 1986
Serological differences between human T-lymphotropic virus type-I (HTLV-I) and HTLV-III/LAVS Harada, D T Purtilo, Y Koyanagi, et al.
Annals of the New York Academy of Sciences|January 1, 1984
A multifactorial model for the development of AIDS in homosexual menJ A Sonnabend, S S Witkin, D T Purtilo
Archives of Pathology & Laboratory Medicine|December 1, 1987
Ontogeny and regulation of the immune systemJ G Sharp, D A Crouse, D T Purtilo
Clinics in Laboratory Medicine|March 1, 1988
Epstein-Barr virus--associated lymphoproliferative lesionsD S Harrington, D D Weisenburger, D T Purtilo
AIDS Research|February 1, 1986
Decision analysis of the HTLV-III screening test for blood donorsL B Ellwein, D T Purtilo, R B Purtilo
International Journal of Cancer|August 15, 1985
Host cell range of adult T-cell leukemia virus. I. Viral infectivity and binding to various cells as detected by flow cytometryF Sinangil, S Harada, D T Purtilo, et al.
International Journal of Cancer|December 15, 1982
Cell-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK)-cell activity in the X-linked lymphoproliferative syndromeS Harada, T Bechtold, J K Seeley, et al.
The American Journal of Medicine|October 1, 1989
Detection of X-linked lymphoproliferative disease using molecular and immunovirologic markersD T Purtilo, H L Grierson, H Ochs, et al.
Cancer Genetics and Cytogenetics|February 1, 1984
Inherited partial trisomy #15 complicated by neuroblastomaW G Sanger, J Howe, R Fordyce, et al.
Pageof 22